ICLUSIG (PONATINIB) TABLETS Trademark

Trademark Overview

On Tuesday, December 18, 2012, a trademark application was filed for ICLUSIG (PONATINIB) TABLETS with the United States Patent and Trademark Office. The USPTO has given the ICLUSIG (PONATINIB) TABLETS trademark a serial number of 85805529. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, July 12, 2024. This trademark is owned by ARIAD Pharmaceuticals, Inc.. The ICLUSIG (PONATINIB) TABLETS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in oncology containing ponatinib
iclusig (ponatinib) tablets

General Information

Serial Number85805529
Word MarkICLUSIG (PONATINIB) TABLETS
Filing DateTuesday, December 18, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, July 12, 2024
Registration Number4460123
Registration DateTuesday, December 31, 2013
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 11, 2013

Trademark Statements

Description of MarkThe mark consists of the word "iclusig" in upper case letters, with the words "(ponatinib) tablets" in lower case letters below it. The first "i" in "iclusig" has a dot over it that is partially encircled.
Certificate of Correction for RegistrationIn the statement, Column 1, line 9-10," underlined" should be deleted. The drawing is corrected to appear as follows: PUBLISH NEW CUT
Goods and ServicesPharmaceutical preparations for use in oncology containing ponatinib
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"PONATINIB" OR "TABLETS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, July 12, 2024
Primary Code005
First Use Anywhere DateFriday, December 14, 2012
First Use In Commerce DateFriday, December 14, 2012

Trademark Owner History

Party NameARIAD Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameARIAD Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameARIAD Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Friday, December 21, 2012NEW APPLICATION ENTERED
Monday, January 7, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 8, 2013NOTICE OF DESIGN SEARCH CODE MAILED
Tuesday, April 2, 2013ASSIGNED TO EXAMINER
Wednesday, April 10, 2013EXAMINERS AMENDMENT -WRITTEN
Wednesday, April 10, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, April 10, 2013EXAMINERS AMENDMENT E-MAILED
Wednesday, April 10, 2013ASSIGNED TO LIE
Thursday, April 11, 2013EXAMINER'S AMENDMENT ENTERED
Thursday, April 11, 2013DATA MODIFICATION COMPLETED
Thursday, April 25, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 3, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 22, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 11, 2013PUBLISHED FOR OPPOSITION
Tuesday, June 11, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 6, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, October 16, 2013TEAS STATEMENT OF USE RECEIVED
Wednesday, October 16, 2013USE AMENDMENT FILED
Monday, November 18, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 20, 2013STATEMENT OF USE PROCESSING COMPLETE
Friday, November 22, 2013ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, November 22, 2013LAW OFFICE REGISTRATION REVIEW COMPLETED
Saturday, November 23, 2013NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, December 31, 2013REGISTERED-PRINCIPAL REGISTER
Monday, November 17, 2014TEAS SECTION 7 REQUEST RECEIVED
Thursday, November 27, 2014CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, November 28, 2014CORRECTION UNDER SECTION 7 - PROCESSED
Monday, October 16, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, December 20, 2016TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, December 20, 2016APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 16, 2017TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, June 22, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, December 31, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, August 22, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 22, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 26, 2019TEAS SECTION 8 & 15 RECEIVED
Wednesday, February 14, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 14, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 26, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, February 24, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, February 24, 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, February 24, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, August 27, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, August 27, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 27, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 27, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, December 31, 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, July 12, 2024CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Thursday, August 27, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Related Keywords

tablets ponatinib iclusig containing oncology preparations pharmaceutical